|Dr. Dewan Fazlul Hoque Chowdhury||Chairman, CEO, Pres & Interim CFO||105.26k||N/A||1973|
|Mr. Christopher J. Avery||VP of Global Bus. Operations||N/A||N/A||1963|
|Ms. Kathryn Farrar||Financial Controller||N/A||N/A||1976|
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is based in New York, New York.
Nemaura Medical Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.